Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Switch Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Switch Therapeutics

Switch Therapeutics

Switch Therapeutics: Pioneering RNAi therapies and nucleic acid nanotechnology for diverse disease treatment.

HQ
San Francisco, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Switch Therapeutics, founded with a mission to revolutionize RNA interference (RNAi) therapies, focuses on integrating nucleic acid nanotechnology to treat a variety of diseases, particularly those affecting the central nervous system. The company's core product is its proprietary Conditionally Activated siRNA (CASi) platform, which combines the advantageous properties of single and double-stranded RNA into a single molecule, enabling efficient self-delivery and targeted treatment.

Notable affiliates include leading scientists and industry experts in RNAi and nanotechnology. The company has garnered attention from prominent investors in the biotech sector, reflecting confidence in its innovative approach. Key achievements include significant advancements in their CASi platform, positioning Switch Therapeutics as a transformative player in genetic medicine. Their impact lies in potentially offering groundbreaking treatments for previously challenging medical conditions.

Switch Therapeutics - Similar Companies

Traversa Therapeutics logo

Traversa Therapeutics

traversathera.com

Sirius Therapeutics logo

Sirius Therapeutics

siriusrna.com

Wayfinder Biosciences logo

Wayfinder Biosciences

wayfinderbio.com

Atalanta Therapeutics logo

Atalanta Therapeutics

atalantatx.com

Silence Therapeutics logo

Silence Therapeutics

Nextrna Therapeutics logo

Nextrna Therapeutics

Sirnaomics logo

Sirnaomics

sirnaomics.com

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Kylin Therapeutics logo

Kylin Therapeutics

Sixfold Bioscience logo

Sixfold Bioscience

sixfold.bio

ReNAgade Therapeutics logo

ReNAgade Therapeutics

Alnylam Pharmaceuticals aln logo

Alnylam Pharmaceuticals aln

alnylam.com

Innovac Therapeutics logo

Innovac Therapeutics

innovactx.com

Shape Therapeutics logo

Shape Therapeutics

shapetx.com

Flashpoint Therapeutics logo

Flashpoint Therapeutics

flashpoint.bio

Switch Therapeutics - Quick Facts

Who are Switch Therapeutics' competitors?

Companies similar to Switch Therapeutics include Traversa Therapeutics, Sirius Therapeutics, Wayfinder Biosciences and Atalanta Therapeutics.

When was Switch Therapeutics founded?

Switch Therapeutics was founded in 2020.

Where is Switch Therapeutics' headquarters located?

Switch Therapeutics' headquarters is located in San Francisco, CA, US.

When was Switch Therapeutics' last funding round?

Switch Therapeutics' most recent funding round was for $52M (USD) in March 2023.

How much has Switch Therapeutics raised to-date?

As of Mar 14, 2023, Switch Therapeutics has raised a total of $52M (USD).

How many employees does Switch Therapeutics have?

Switch Therapeutics has 16 employees as of Feb 5, 2024.

Switch Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Nanotechnology
  • RNAI
Main Product
  • Rnai Therapies
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified